168 related articles for article (PubMed ID: 16280851)
1. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model.
Wang ZG; Durand DB; Schoenberg M; Pan YT
J Urol; 2005 Dec; 174(6):2376-81. PubMed ID: 16280851
[TBL] [Abstract][Full Text] [Related]
2. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
[TBL] [Abstract][Full Text] [Related]
3. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
Ren H; Park KC; Pan R; Waltzer WC; Shroyer KR; Pan Y
J Urol; 2012 Mar; 187(3):1063-70. PubMed ID: 22245332
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Schmidbauer J; Remzi M; Klatte T; Waldert M; Mauermann J; Susani M; Marberger M
Eur Urol; 2009 Dec; 56(6):914-9. PubMed ID: 19674831
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Goh AC; Tresser NJ; Shen SS; Lerner SP
Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
[TBL] [Abstract][Full Text] [Related]
6. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
7. Detection of tumorigenesis in rat bladders with optical coherence tomography.
Pan Y; Lavelle JP; Bastacky SI; Meyers S; Pirtskhalaishvili G; Zeidel ML; Farkas DL
Med Phys; 2001 Dec; 28(12):2432-40. PubMed ID: 11797946
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
[TBL] [Abstract][Full Text] [Related]
9. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
10. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
11. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
[TBL] [Abstract][Full Text] [Related]
12. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
13. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
14. Cross-polarization optical coherence tomography for early bladder-cancer detection: statistical study.
Gladkova N; Streltsova O; Zagaynova E; Kiseleva E; Gelikonov V; Gelikonov G; Karabut M; Yunusova K; Evdokimova O
J Biophotonics; 2011 Aug; 4(7-8):519-32. PubMed ID: 21780300
[TBL] [Abstract][Full Text] [Related]
15. Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.
Ren H; Yuan Z; Waltzer W; Shroyer K; Pan Y
J Urol; 2010 Oct; 184(4):1499-506. PubMed ID: 20723922
[TBL] [Abstract][Full Text] [Related]
16. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
[TBL] [Abstract][Full Text] [Related]
18. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
19. Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography.
Pan YT; Xie TQ; Du CW; Bastacky S; Meyers S; Zeidel ML
Opt Lett; 2003 Dec; 28(24):2485-7. PubMed ID: 14690122
[TBL] [Abstract][Full Text] [Related]
20. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
Cauberg EC; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; de Reijke TM
Eur Urol; 2009 Aug; 56(2):287-96. PubMed ID: 19285787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
